Home / I.V. Therapy / I.V. Therapy Accessories / Platinum Vena Cava Filter / Platinum Vena Cava Filter CelectG34502
Picture of Platinum Vena Cava Filter CelectG34502

Platinum Vena Cava Filter CelectG34502

Platinum-Vena-Cava-Filter-CelectG34502

SKU #

#1062116

MPN #

G34502

Brand

Cook Medical

Stock

In Stock

Quantity

100

Features

FILTER SET, VENA CAVA F/FEMORAL VEIN PLATINUM

$2,313.04 USD

Product Specifications Product Usage Additional Information
Print
Attribute Name Attribute Value
McKesson # 1062116
Manufacturer # G34502
Brand Celect
Manufacturer Cook Medical
Application Platinum Vena Cava Filter
For Use With For Femoral Vein Platinum
Specifications 30 X 49 mm, Platinum, 7 Fr., 79 cm Catheter Length, 65 cm Sheath Length, With Femoral NavAlign Delivery
UNSPSC Code 42203414
Compare Selected Items Email

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • Preloaded on a filter introducer, the filter has four radiopaque platinum markers for accurate placement
  • The filter has a 7 Fr. coaxial introducer system and a hydrophilic-coated 10 Fr. predilator
  • The NavAlign™ multipurpose dilator includes radiopaque sizing bands and flushing sideports
  • Pulmonary thromboembolism when anticoagulant therapy is contraindicated
  • Failure of anticoagulant therapy in thromboembolic diseases
  • Emergency treatment following massive PE where anticipated benefits of conventional therapy are reduced
  • Chronic, recurrent PE where anticoagulant therapy has failed or is contraindicated